Newsletter | November 6, 2021

11.06.21 -- Researchers Invent Chemical Reaction That Could Accelerate Drug Discovery

 
Webinar
Industry Insights
Expanding The Boundaries Of Sub-Cutaneous Injections

As the field of biologics increases its focus on identifying new diseases to target, novel constructs to treat those diseases, and innovative administration devices that include self-administration technologies to improve compliance and patient quality of life.

Process Effects On Drug Product Quality In Pharmaceutical Manufacturing — A Validated Measurement Process

This white paper discusses the importance of understanding how critical process parameters can impact a product’s critical quality attributes, and how a systematic approach with validated SPR assays can help in this respect.

Cell Clearance Of E. coli And S. cerevisiae Cultures And Lysate Filtration With AcroPrep 24-well Cell Clarification And Sterile Filtration Plates

Overexpression of proteins has enabled access to highly purified proteins in large quantities for research and increasingly for medical purposes. However, the clarification process can be quite cumbersome, especially during early discovery, when working with multiple cultures of relatively small culture volumes. 

Regulatory Services For Accelerated Development And Commercialization

Breakthrough therapy designations and other expedited regulatory reviews enable more innovation on shorter timelines to the clinic and commercialization, but they require careful navigation.

Local Delivery For Treatment Of Lung Cancer: Manufacturing Formulations For Dry Powder Inhaler By Spray Drying

Explore two case studies where lung cancer therapies were delivered to the lung by dry powder inhaler in a rat model and evaluated for efficacy. The results confirmed that local delivery is a promising route to treat lung cancer.

Most Popular News
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.